BRIDGEBIO PHARMA, INC.
BRIDGEBIO PHARMA, INC. is a registered legal entity registered in United States under 4280884, and its current status with California Secretary of State — bizfile Online is active. The company was incorporated on 29 May 2019 and lists its registered address as United States. 2 shareholders are on record for BRIDGEBIO PHARMA, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from California Secretary of State — bizfile Online and was last updated on 11 August 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
2
Two shareholders are currently on record for BRIDGEBIO PHARMA, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Frazier Life Sciences Management, L.P. , holding 3% — the largest recorded stake — followed by Fidelity Salem Street Trust-Fidelity Small Cap Index Fund at 1.3%.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 3% | California Secretary of State — bizfile Online | |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.3% | California Secretary of State — bizfile Online |
Officers
5
The Co-founder, Chairman Of Pharmaceuticals & Independent Lead Director of BRIDGEBIO PHARMA, INC. on record is Charles J. Homcy M.d.; 5 officers are shown here, filed with California Secretary of State — bizfile Online.
The register reports 17 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at BRIDGEBIO PHARMA, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
BRIDGEBIO PHARMA, INC. has no recorded parent company — it sits at the top of its own group structure, with 34 subsidiaries recorded beneath it across 5 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 34 subsidiaries span United States, Netherlands, Cayman Islands, Germany, Switzerland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Three of the 34 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
BRIDGEBIO PHARMA, INC.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns BRIDGEBIO PHARMA, INC.?
Two shareholders are currently on record for BRIDGEBIO PHARMA, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Frazier Life Sciences Management, L.P. , holding 3% — the largest recorded stake — followed by Fidelity Salem Street Trust-Fidelity Small Cap Index Fund at 1.3%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is BRIDGEBIO PHARMA, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for BRIDGEBIO PHARMA, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does BRIDGEBIO PHARMA, INC. have on record?
2 shareholders are shown on record for BRIDGEBIO PHARMA, INC..
What is BRIDGEBIO PHARMA, INC.'s company registration number?
BRIDGEBIO PHARMA, INC.'s registration number is 4280884, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is active.
Is BRIDGEBIO PHARMA, INC. still an active company?
BRIDGEBIO PHARMA, INC.'s status on California Secretary of State — bizfile Online is listed as active.
When was BRIDGEBIO PHARMA, INC. incorporated?
BRIDGEBIO PHARMA, INC. was incorporated on 29 May 2019, according to California Secretary of State — bizfile Online.
What is BRIDGEBIO PHARMA, INC.'s registered address?
The registered address on file for BRIDGEBIO PHARMA, INC. is United States.
Who are the officers/directors of BRIDGEBIO PHARMA, INC.?
The Co-founder, Chairman Of Pharmaceuticals & Independent Lead Director of BRIDGEBIO PHARMA, INC. on record is Charles J. Homcy M.d.; 5 officers are shown here, filed with California Secretary of State — bizfile Online. Management authority at BRIDGEBIO PHARMA, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does BRIDGEBIO PHARMA, INC. have a parent company or subsidiaries?
BRIDGEBIO PHARMA, INC. has no recorded parent company — it sits at the top of its own group structure, with 34 subsidiaries recorded beneath it across 5 jurisdictions. Those 34 subsidiaries span United States, Netherlands, Cayman Islands, Germany, Switzerland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Three of the 34 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to BRIDGEBIO PHARMA, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to BRIDGEBIO PHARMA, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access BRIDGEBIO PHARMA, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like BRIDGEBIO PHARMA, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 11 August 2026.